rs138379074

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The ENST00000382292.9(SACS):​c.6640C>T​(p.Arg2214Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000169 in 1,613,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2214L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00017 ( 0 hom. )

Consequence

SACS
ENST00000382292.9 missense

Scores

8
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 4.01

Publications

4 publications found
Variant links:
Genes affected
SACS (HGNC:10519): (sacsin molecular chaperone) This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
SACS Gene-Disease associations (from GenCC):
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.25719666).

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000382292.9. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
NM_014363.6
MANE Select
c.6640C>Tp.Arg2214Cys
missense
Exon 10 of 10NP_055178.3
SACS
NM_001437336.1
c.6667C>Tp.Arg2223Cys
missense
Exon 11 of 11NP_001424265.1
SACS
NM_001278055.2
c.6199C>Tp.Arg2067Cys
missense
Exon 8 of 8NP_001264984.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
ENST00000382292.9
TSL:5 MANE Select
c.6640C>Tp.Arg2214Cys
missense
Exon 10 of 10ENSP00000371729.3
SACS
ENST00000455470.6
TSL:1
c.2431+4209C>T
intron
N/AENSP00000406565.2
SACS
ENST00000682944.1
c.6667C>Tp.Arg2223Cys
missense
Exon 11 of 11ENSP00000507173.1

Frequencies

GnomAD3 genomes
AF:
0.000158
AC:
24
AN:
152074
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000131
AC:
33
AN:
251046
AF XY:
0.000133
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.0000868
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000212
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000169
AC:
247
AN:
1461642
Hom.:
0
Cov.:
37
AF XY:
0.000154
AC XY:
112
AN XY:
727114
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33476
American (AMR)
AF:
0.0000447
AC:
2
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39684
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86244
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53346
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.000201
AC:
223
AN:
1111902
Other (OTH)
AF:
0.000132
AC:
8
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000164
AC:
25
AN:
152192
Hom.:
0
Cov.:
33
AF XY:
0.000175
AC XY:
13
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41520
American (AMR)
AF:
0.000131
AC:
2
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
67998
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000215
Hom.:
0
Bravo
AF:
0.000162
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000988
AC:
12
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions as Germline

Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
Charlevoix-Saguenay spastic ataxia (3)
-
1
-
Inborn genetic diseases (1)
-
1
-
not provided (1)
-
-
1
Spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.23
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.22
T
Eigen
Benign
0.078
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.70
T
M_CAP
Benign
0.061
D
MetaRNN
Benign
0.26
T
MetaSVM
Uncertain
-0.24
T
MutationAssessor
Benign
0.55
N
PhyloP100
4.0
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-1.3
N
REVEL
Uncertain
0.38
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.010
D
Polyphen
0.39
B
Vest4
0.17
MVP
0.87
ClinPred
0.034
T
GERP RS
5.1
Varity_R
0.097
gMVP
0.60
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138379074; hg19: chr13-23911375; COSMIC: COSV101207433; API